EOM Pharmaceuticals IMUC Stock
EOM Pharmaceuticals Price Chart
EOM Pharmaceuticals IMUC Financial and Trading Overview
| EOM Pharmaceuticals stock price | 0.19 USD |
| Previous Close | 0.21 USD |
| Open | 0.19 USD |
| Bid | 0.2 USD x 500000 |
| Ask | 0.27 USD x 500000 |
| Day's Range | 0.19 - 0.19 USD |
| 52 Week Range | 0.04 - 0.34 USD |
| Volume | 23 USD |
| Avg. Volume | 7.53K USD |
| Market Cap | 26.57M USD |
| Beta (5Y Monthly) | 0.341 |
| PE Ratio (TTM) | 0.01797945 |
| EPS (TTM) | 10.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IMUC Valuation Measures
| Enterprise Value | 26.32M USD |
| Trailing P/E | 0.01797945 |
| Forward P/E | -0.328125 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
EOM Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.341 |
| 52-Week Change | 238.70% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.34 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.14 USD |
| 200-Day Moving Average | 0.14 USD |
IMUC Share Statistics
| Avg. Volume (3 month) | 7.53K USD |
| Avg. Daily Volume (10-Days) | 3.64K USD |
| Shares Outstanding | 126.5M |
| Float | 5.7M |
| Short Ratio | 4.13 |
| % Held by Insiders | 94.96% |
| % Held by Institutions | 0% |
| Shares Short | 165.95K |
| Short % of Float | 3.96% |
| Short % of Shares Outstanding | 3.96% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -440.44% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5127658 USD |
| Diluted EPS (ttm) | 11.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 551.18K USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 3.05M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.972 |
| Book Value Per Share (mrq) | -0.033 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2785943 USD |
| Levered Free Cash Flow (ttm) | -1987797 USD |
Profile of EOM Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Montvale |
| Address | 136 Summit Avenue |
| ZIP | 07645 |
| Phone | 201 351 0605 |
| Website | https://eompharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company's lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.
Q&A For EOM Pharmaceuticals Stock
What is a current IMUC stock price?
EOM Pharmaceuticals IMUC stock price today per share is 0.19 USD.
How to purchase EOM Pharmaceuticals stock?
You can buy IMUC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for EOM Pharmaceuticals?
The stock symbol or ticker of EOM Pharmaceuticals is IMUC.
Which industry does the EOM Pharmaceuticals company belong to?
The EOM Pharmaceuticals industry is Biotechnology.
How many shares does EOM Pharmaceuticals have in circulation?
The max supply of EOM Pharmaceuticals shares is 126.5M.
What is EOM Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
EOM Pharmaceuticals PE Ratio is 0.01799242 now.
What was EOM Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
EOM Pharmaceuticals EPS is 10.56 USD over the trailing 12 months.
Which sector does the EOM Pharmaceuticals company belong to?
The EOM Pharmaceuticals sector is Healthcare.